Funder
European Molecular Biology Organization (EMBO)
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Schiffmann, R. Fabry disease. Handb Clin Neurol 132, 231–248 (2015).
2. Fogo, A. B. et al. Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). 25, 2168–2177 (2010).
3. Eng, C. M. et al. Safety and efficacy of recombinant human alpha-galactosidase A–replacement therapy in Fabry’s disease. N. Engl. J. Med. 345, 9–16 (2001).
4. Schiffmann, R. et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285, 2743–2749 (2001).
5. Talbot, A., Nicholls, K., Fletcher, J. M. & Fuller, M. A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease. Molecular Genetics and Metabolism 122, 121–125 (2017).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献